Epstein Index›Documents›EFTA02714282
💨IMPACT LEVEL 1 — MEH

Epstein File EFTA02714282: Solicitation, Targeted and Treat (DS11)

General DocumentDate unavailableEFTA027142821 keyword hits
0
views
0
shares
0
reactions
0
persons
3
keywords
5
excerpts

This document describes a company's proprietary systematic delivery system for targeted drug delivery to disease tissues and cells. It references partnerships with Quark and Pfizer, Phase I development for PKN3-targeted cancer siRNA, and pipeline products in development to treat cancer and viral infections using gene silencing technology. A standard disclaimer states the document is not intended as a securities solicitation.

👤 Named in This Document
No named persons linked yet
🔑 Evidence Keywords

📋 Key Excerpts5

PersonKeyword
Excerpt 1
This document is not intended as an offer or **solicitation** with respect to the purchase or sale of any security.
Excerpt 2
Silence also has developed a proprietary systematic delivery system to deliver molecules to **targeted** disease tissues and cells.
Excerpt 3
The Company is lead drug partner with Quark & Pfizer and is on Phase I for PKN3-**targeted** cancer siRNA.

Discussion

Let the world know how you feel.

What you just read should make you angry. Channel that into 17 syllables. Our AI helps you craft a haiku in seconds — then share it with the world.

Power hides in dark But sunlight finds every crack Truth cannot be bought

— Sarah K., after reading this document
✍️ Write Your Haiku

Haikus for Humanity — 5 · 7 · 5

React
Share𝕏🦋FBinFund Accountability